Nuvectis Pharma(NVCT) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Nuvectis Pharma, Inc. Reports Second Quarter 2024 Financial Results and Business Highlights August 6, 2024, Fort Lee, NJ - Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the second quarter 2024 and provided an update on recent business progress. Ron Bentsur, ...